Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionpantothenate kinase activity

PANK1 PANK2 PANK3

3.59e-0641943GO:0004594
GeneOntologyMolecularFunctiongrowth factor receptor binding

PSEN1 PSG6 PSG9 ADAM17 KLB GRIN2B FAM83B GLMN IRAK4

5.04e-051731949GO:0070851
GeneOntologyMolecularFunctionCTP synthase activity

CTPS2 CTPS1

9.39e-0521942GO:0003883
GeneOntologyMolecularFunctionATP-dependent activity

MYH6 ABCA1 MYO6 NAIP CHD3 CHD4 KIF2B NAV3 HFM1 HSP90AB1 FIGNL2 SMC4 ATP2C1 ABCA6 DYNC1LI1 MACF1 HSP90AB2P

1.09e-0461419417GO:0140657
GeneOntologyMolecularFunctionATP hydrolysis activity

ABCA1 NAIP CHD3 CHD4 KIF2B NAV3 HFM1 HSP90AB1 FIGNL2 SMC4 ATP2C1 ABCA6 MACF1 HSP90AB2P

1.10e-0444119414GO:0016887
GeneOntologyCellularComponentanchoring junction

KLHL24 PSG6 PSG9 ITGB1BP1 TRPC6 SRP68 ITGA4 ADAM17 EVL NRAP DSG3 DSP EPB41L5 TEC CBL KRIT1 AFAP1 IGF2R HMCN1 IL1RL1 CTNNA2 CGNL1 OCLN

3.94e-0597619423GO:0070161
GeneOntologyCellularComponentbasal plasma membrane

ABCA1 PSG6 PSG9 NAIP AP2A1 PTPRQ HSP90AB1 DSP SLC7A7 LEPR SLCO5A1 CTNNA2

1.23e-0435419412GO:0009925
GeneOntologyCellularComponentcell-cell junction

KLHL24 PSG6 PSG9 TRPC6 ITGA4 ADAM17 NRAP DSG3 DSP EPB41L5 TEC KRIT1 HMCN1 CTNNA2 CGNL1 OCLN

1.34e-0459119416GO:0005911
GeneOntologyCellularComponentbasolateral plasma membrane

ABCA1 PSG6 PSG9 NAIP AP2A1 HSP90AB1 DSP SLC7A7 LEPR SLCO5A1 CTNNA2

2.09e-0432019411GO:0016323
GeneOntologyCellularComponentbasal part of cell

ABCA1 PSG6 PSG9 NAIP AP2A1 PTPRQ HSP90AB1 DSP SLC7A7 LEPR SLCO5A1 CTNNA2

2.26e-0437819412GO:0045178
GeneOntologyCellularComponentcytoophidium

CTPS2 CTPS1

2.55e-0431942GO:0097268
DomainType_II_PanK

PANK1 PANK2 PANK3

4.05e-0641893IPR004567
DomainFumble

PANK1 PANK2 PANK3

4.05e-0641893PF03630
DomainCTP_synthase_N

CTPS2 CTPS1

1.02e-0421892IPR017456
DomainGATase1_CTP_Synthase

CTPS2 CTPS1

1.02e-0421892IPR033828
DomainCTP_synthase

CTPS2 CTPS1

1.02e-0421892IPR004468
DomainCTP_synth_N

CTPS2 CTPS1

1.02e-0421892PF06418
DomainCHD_N

CHD3 CHD4

3.04e-0431892IPR012958
DomainCHD_C2

CHD3 CHD4

3.04e-0431892IPR012957
DomainCHDCT2

CHD3 CHD4

3.04e-0431892PF08074
DomainCHDNT

CHD3 CHD4

3.04e-0431892PF08073
DomainDUF1086

CHD3 CHD4

3.04e-0431892IPR009462
DomainDUF1087

CHD3 CHD4

3.04e-0431892IPR009463
DomainDUF1087

CHD3 CHD4

3.04e-0431892PF06465
DomainDUF1086

CHD3 CHD4

3.04e-0431892PF06461
DomainDUF1087

CHD3 CHD4

3.04e-0431892SM01147
DomainDUF1086

CHD3 CHD4

3.04e-0431892SM01146
PathwayREACTOME_COENZYME_A_BIOSYNTHESIS

PANK1 PANK2 PANK3

3.26e-0571403M27087
PathwayREACTOME_COENZYME_A_BIOSYNTHESIS

PANK1 PANK2 PANK3

3.26e-0571403MM14765
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

SERBP1 MYO6 SRP68 PSMD3 DDB1 PARP1 HSP90AB1 KPNA2 DSP ICE2 CIP2A SMC4 EPB41L5 ARHGAP39 ERLIN1 FAM83B IGF2R MACF1 OCLN PLCH1 CTPS1 CNOT1

1.27e-107081972239231216
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

MYH6 CENPC PSMD3 CHD3 CHD4 PARP1 AP2A1 SACS TMPRSS7 USP1 KIAA2012 AGAP2 HSP90AB1 EVL ABI3BP PCDHGB2 KDM5A PCDHGB1 DSP SMC4 APOB RNF17 ERLIN1 SUGCT C4orf51 OGDHL DNAJC5 MACF1 MYOM2 PLCH1

7.91e-1014421973035575683
Pubmed

KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.

MYH6 SERBP1 MYO6 SRP68 PSMD3 CHD3 DDB1 MRPS22 PARP1 AP2A1 SACS PLP1 AGAP2 HSP90AB1 EVL DSP GRIN2B ARHGAP39 LDHB GDA AFAP1 PDE4DIP OGDHL MACF1 CTNNA2 CGNL1 PLCH1 CNOT1

1.16e-0814311972837142655
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

ORC6 SRP68 PSMD3 CHD3 CHD4 DDB1 PARP1 XPO6 HSP90AB1 KPNA2 DSP POLD1 SMC4 RNF17 DYNC1LI1 MACF1 CNOT1

4.37e-085821971720467437
Pubmed

Defining the membrane proteome of NK cells.

SERBP1 MYO6 ORC6 PSMD3 CHD4 ITGA4 LMBRD2 PARP1 AP2A1 PIK3CG GLG1 ADAM17 AGAP2 HSP90AB1 KPNA2 EVL POLD1 LDHB ATP2C1 IGF2R DYNC1LI1 DNAJC5 CTPS1 CNOT1

5.78e-0811681972419946888
Pubmed

Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex.

MYO6 DOCK11 SRP68 PSMD3 CHD4 DDB1 PARP1 DOCK6 HSP90AB1 DSP POLR2B SMC4 LDHB CTPS1

7.74e-083991971437536630
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

MYO6 TTC14 SACS ELAPOR1 CIP2A EPB41L5 ARHGAP39 FAN1 GDA ATP2C1 CNTNAP4 MACF1 CGNL1 PLCH1 TMEM63A

1.66e-074931971515368895
Pubmed

Crystal structures of human pantothenate kinases. Insights into allosteric regulation and mutations linked to a neurodegeneration disorder.

PANK1 PANK2 PANK3

1.79e-073197317631502
Pubmed

Compartmentalization of mammalian pantothenate kinases.

PANK1 PANK2 PANK3

1.79e-073197323152917
Pubmed

Chemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme A homeostasis.

PANK1 PANK2 PANK3

1.79e-073197317379144
Pubmed

The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.

CDK16 SERBP1 SRP68 PSMD3 CHD3 CHD4 EFHB DDB1 MRPS22 PARP1 AP2A1 HSP90AB1 KPNA2 WASHC4 KDM5A DSP SMC4 LDHB IGF2R ZCRB1 DYNC1LI1 MACF1 HSP90AB2P

1.88e-0711531972329845934
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

SERBP1 SAMD9 MYO6 SRP68 PSMD3 ITGA4 DDB1 MRPS22 ITIH2 DECR1 PARP1 AP2A1 HSP90AB1 KPNA2 DSG3 DSP POLR2B SMC4 LDHB ERLIN1 FAM83B AFAP1 CSTA CTPS1

2.22e-0712571972436526897
Pubmed

Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.

TDRD15 MYH6 SERBP1 SRP68 PSMD3 CHD3 MAP3K1 AP2A1 HSP90AB1 KPNA2 DSP LDHB GDA HMCN1 CSTA MACF1 HSP90AB2P CTNNA2 CTPS1

3.91e-078441971925963833
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

CDK16 DOCK11 FSIP2 BMX PANK2 DOCK6 PANK3 KDM5A DSP EPB41L5 RAB11FIP1 CBL FAM83B SLF2 MACF1 PLEKHM3 CGNL1 PLCH1 EDRF1

5.28e-078611971936931259
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

SERBP1 MYO6 SRP68 PSMD3 CHD4 DDB1 MRPS22 PARP1 AP2A1 HSP90AB1 KPNA2 PSAT1 DSP POLD1 CIP2A POLR2B SMC4 LDHB DYNC1LI1 MACF1 CTPS1 CNOT1

7.02e-0711491972235446349
Pubmed

Germline deletion of pantothenate kinases 1 and 2 reveals the key roles for CoA in postnatal metabolism.

PANK1 PANK2 PANK3

7.13e-074197322815849
Pubmed

Coenzyme A metabolism.

PANK1 PANK2 PANK3

7.13e-07419732981478
Pubmed

A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.

PANK1 PANK2 PANK3

7.13e-074197311479594
Pubmed

A protein interaction landscape of breast cancer.

CDK16 PSEN1 MYO6 SRP68 MRPS22 PARP1 AP2A1 NUAK1 EVL CIP2A ERLIN1 FAM83B ATP2C1 IGF2R MACF1 CTNNA2

7.73e-076341971634591612
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

CENPC MYO6 SRP68 PSMD3 CHD4 DDB1 DECR1 PARP1 AP2A1 HSP90AB1 WASHC4 DSP POLD1 POLR2B SMC4 EPB41L5 LDHB ERLIN1 PRIM2 CSTA DYNC1LI1 MACF1 HSP90AB2P CTPS1

8.23e-0713531972429467282
Pubmed

USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease.

SERBP1 MYO6 PSMD3 DDB1 PARP1 CTPS2 GMDS HSP90AB1 KPNA2 LDHB ERLIN1 ATP2C1 DYNC1LI1 HSP90AB2P CTPS1

9.27e-075651971533567341
Pubmed

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.

CDK16 ITGA4 RGP1 CTPS2 AP2A1 EPB41L5 RAB11FIP1 CBL FAM83B IGF2R MACF1 OCLN PLCH1

9.63e-074211971336976175
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

SERBP1 PARP1 UTY HSP90AB1 DSP FAT3 LEPR MACF1 CGNL1 PLCH1

1.01e-062341971036243803
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

SRP68 CHD4 DDB1 MRPS22 PARP1 AP2A1 SACS DOCK6 HSP90AB1 KPNA2 SUPT20H KDM5A DSP POLR2B ARHGAP39 LDHB AFAP1 IRAK4 DYNC1LI1 MACF1 CNOT1

1.03e-0610821972138697112
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

USP34 MYO6 CHD4 BICD1 PARP1 PTPRD AP2A1 SACS NAV3 PLP1 AGAP2 HSP90AB1 SUPT20H WASHC4 KDM5A DSP GRIN2B KRIT1 FAN1 GMCL1 SLF2 PDE4DIP MACF1

1.22e-0612851972335914814
Pubmed

Phosphoproteomic analysis of the developing mouse brain.

USP34 SERBP1 PSEN1 ITIH2 FAT4 ARHGAP39 AFAP1 DYNC1LI1 CTNNA2 PLCH1

1.58e-062461971015345747
Pubmed

HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.

SERBP1 SRP68 PSMD3 CHD4 PARP1 KPNA2 FAT4 DSP POLR2B SMC4 APOB RAB11FIP1 RNF17 TSPAN3 SETDB2 ATP2C1 CTPS1

1.61e-067541971735906200
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

SERBP1 SRP68 PSMD3 CHD4 DDB1 MRPS22 DECR1 PARP1 CTPS2 AP2A1 GLG1 GMDS HSP90AB1 KPNA2 DSP POLD1 POLR2B SMC4 LDHB GDA PRIM2 MACF1 HSP90AB2P CTPS1

1.80e-0614151972428515276
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

SERBP1 MYO6 RGS22 SRP68 PSMD3 CHD4 DDB1 PARP1 AP2A1 HSP90AB1 KPNA2 PSAT1 DSP POLD1 POLR2B SMC4 APOB LDHB GLMN IGF2R CSTA DYNC1LI1 CTPS1 CNOT1

2.03e-0614251972430948266
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

USP34 SERBP1 PSMD3 CHD4 LMBRD2 DDB1 MRPS22 DECR1 PARP1 KPNA2 PSAT1 POLD1 CIP2A POLR2B SMC4 ERLIN1 GLMN AFAP1 CSTA DYNC1LI1 HSP90AB2P CTNNA2 CTPS1 CNOT1

2.43e-0614401972430833792
Pubmed

ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.

SERBP1 MYO6 PSMD3 DDB1 PARP1 AP2A1 HSP90AB1 KPNA2 LDHB ERLIN1

3.40e-062681971033024031
Pubmed

A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.

SLC38A9 LMBRD2 MRPS22 XPO6 ADAM17 NEMP1 CIP2A EPB41L5 ARHGAP39 RAB11FIP1 SLC7A7 TSPAN3 IGF2R PRIM2 DNAJC5 MACF1

3.89e-067191971635337019
Pubmed

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

SRP68 PSMD3 CHD4 DDB1 PARP1 HSP90AB1 KPNA2 POLD1 CIP2A POLR2B SMC4 PRIM2 DYNC1LI1 CTPS1 CNOT1

4.09e-066381971533239621
Pubmed

Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.

SRP68 PARP1 AP2A1 GLG1 HSP90AB1 KPNA2 DSP POLR2B SMC4 APOB RAB11FIP1 ERLIN1 TMEM106B GLMN GDA AFAP1 IGF2R CSTA MACF1 CTNNA2 CTPS1 CNOT1

4.99e-0612971972233545068
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

NAIP ADCY5 AP2A1 SACS AGAP2 HSP90AB1 GRIN2B ARHGAP39 DNAJC5 MACF1 CTNNA2

5.23e-063471971117114649
Pubmed

HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways.

USP34 SRP68 PSMD3 DDB1 MRPS22 GMDS HSP90AB1 CIP2A POLR2B LDHB TMEM106B IGF2R DYNC1LI1 CTPS1

5.38e-065711971437167062
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

ITGB1BP1 SRP68 CHD4 PRKD3 USP1 HSP90AB1 NRAP KDM5A DSP BRMS1L PDE4DIP MACF1 MYOM2

5.90e-064971971323414517
Pubmed

Mapping specific protein-protein interactions within the core component of the breast cell DNA synthesome.

PARP1 POLD1 PRIM2

6.16e-06719739563011
Pubmed

LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.

MYO6 SRP68 CTPS2 AP2A1 XPO6 HSP90AB1 KPNA2 NEMP1 CIP2A POLR2B SMC4 TSPAN3 ERLIN1 GLMN ATP2C1 IGF2R DYNC1LI1 OCLN

7.83e-069421971831073040
Pubmed

Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.

USP34 SERBP1 MYO6 SRP68 PSMD3 CHST9 CHD3 CHD4 DDB1 MRPS22 PARP1 CTPS2 AP2A1 HSP90AB1 KPNA2 WASHC4 ICE2 POLR2B LDHB PRIM2 HSP90AB2P CTPS1

7.85e-0613351972229229926
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

CENPC PSMD3 PARP1 PTPRD USP1 HSP90AB1 KPNA2 PSAT1 DSP CIP2A POLR2B ARHGAP39 RAB11FIP1 PTPRT FAN1 GLMN IGF2R PRIM2 CNOT1

9.23e-0610491971927880917
Pubmed

ROR2 Downregulation Activates the MSX2/NSUN2/p21 Regulatory Axis and Promotes Dental Pulp Stem Cell Senescence.

MYH6 SERBP1 PARP1 HSP90AB1 PSAT1 DSP LDHB

1.04e-05131197735356984
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

DOCK11 CHD4 DDB1 PARP1 PTPRD AP2A1 PLP1 AGAP2 HSP90AB1 KDM5A GRIN2B ARHGAP39 GDA IGF2R PDE4DIP MACF1 CTNNA2 CNOT1

1.05e-059631971828671696
Pubmed

Epidermal development requires ninein for spindle orientation and cortical microtubule organization.

DSG3 DSP CTNNA2 OCLN

1.35e-0526197430923192
Pubmed

Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.

SERBP1 PSMD3 CHD3 STAT2 DECR1 PARP1 HSP90AB1 PSAT1 POLR2B SMC4 LDHB MACF1 HSP90AB2P

1.37e-055381971328524877
Pubmed

The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.

USP34 ZNF765 CENPC PSMD3 CHD4 PARP1 AP2A1 GLG1 ADAM17 HSP90AB1 WASHC4 DSP CIP2A CBL ERLIN1 TMEM106B ATP2C1 IGF2R OCLN CNOT1

1.84e-0512031972029180619
Pubmed

An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells.

PSMD3 PARP1 GLG1 HSP90AB1 KPNA2 PSAT1 DSP SMC4 LDHB CSTA CTPS1

1.84e-053971971121319273
Pubmed

PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

MYO6 SRP68 PSMD3 CHD4 PARP1 HSP90AB1 PSAT1 DSP SMC4 LDHB CSTA CTPS1

1.99e-054771971231300519
Pubmed

A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.

MYO6 PSMD3 DDB1 AP2A1 GLG1 HSP90AB1 POLR2B SMC4 GLMN DYNC1LI1 OCLN CTPS1 CNOT1

2.08e-055601971335241646
Pubmed

Quantitative trait loci that determine plasma lipids and obesity in C57BL/6J and 129S1/SvImJ inbred mice.

ANGPTL3 LEPR IGF2R

2.09e-0510197315210844
Pubmed

Common variants near ABCA1, AFAP1 and GMDS confer risk of primary open-angle glaucoma.

ABCA1 GMDS AFAP1

2.09e-0510197325173105
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

USP34 SRP68 DDB1 STAT2 USP1 ICE2 CIP2A POLR2B EPB41L5 GLMN IGF2R DYNC1LI1 DNAJC5 PLCH1 CTPS1

2.10e-057331971534672954
Pubmed

Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.

PSMD3 CHD4 DDB1 NAV3 HSP90AB1 DSP POLR2B EPB41L5 LDHB IGF2R GUCY2C PRIM2 TMEM63A

2.24e-055641971321565611
Pubmed

A cohesin-RAD21 interactome.

CHD4 DDB1 HSP90AB1 EVL SMC4 APOB CSTA CTPS1

2.65e-05208197822145905
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

SRP68 PSMD3 DDB1 PARP1 HSP90AB1 KPNA2 DSP LRRK1 LDHB HSP90AB2P CTPS1 CNOT1

2.80e-054941971226831064
Pubmed

Lis1 is essential for cortical microtubule organization and desmosome stability in the epidermis.

DSG3 DSP CTNNA2

2.86e-0511197321844209
Pubmed

Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.

SERBP1 MYO6 PSMD3 CHD3 CHD4 MRPS22 PARP1 HSP90AB1 DSP SMC4 LDHB ERLIN1 DYNC1LI1 DNAJC5 MACF1 HSP90AB2P

2.92e-058471971635235311
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

USP34 SERBP1 SRP68 PSMD3 DDB1 CTPS2 GMDS HSP90AB1 KPNA2 PSAT1 WASHC4 POLD1 POLR2B SMC4 LDHB GDA PRIM2 DYNC1LI1 MACF1 HSP90AB2P CTPS1 CNOT1

2.93e-0514551972222863883
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

SERBP1 SRP68 PSMD3 CHD3 CHD4 DDB1 MRPS22 MAP3K1 DECR1 AP2A1 KPNA2 POLR2B OGDHL MACF1 CNOT1

3.13e-057591971535915203
Pubmed

A genome-wide association study provides evidence for association of chromosome 8p23 (MYP10) and 10q21.1 (MYP15) with high myopia in the French Population.

ABCA1 CHD4 PTPRD NAV3

3.17e-0532197423049088
Pubmed

The human cytoplasmic dynein interactome reveals novel activators of motility.

SERBP1 PKD1L1 DDB1 BICD1 DECR1 HSP90AB1 DSP CIP2A POLR2B ERLIN1 FAM83B GLMN IGF2R DYNC1LI1 CGNL1 CNOT1

3.18e-058531971628718761
Pubmed

Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation.

ITGB1BP1 KRIT1

3.19e-052197211741838
Pubmed

Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion.

ABCA1 APOB

3.19e-052197228694219
Pubmed

The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation.

CHD3 CHD4

3.19e-05219727575689
Pubmed

The N-terminal Region of Chromodomain Helicase DNA-binding Protein 4 (CHD4) Is Essential for Activity and Contains a High Mobility Group (HMG) Box-like-domain That Can Bind Poly(ADP-ribose).

CHD4 PARP1

3.19e-052197226565020
Pubmed

Identification of the human PMR1 mRNA endonuclease as an alternatively processed product of the gene for peroxidasin-like protein.

PXDNL ATP2C1

3.19e-052197222543864
Pubmed

The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cells.

TLR7 IRAK4

3.19e-052197232487715
Pubmed

Increased levels of the megakaryocyte and platelet expressed cysteine proteases stefin A and cystatin A prevent thrombosis.

LEPR CSTA

3.19e-052197231270351
Pubmed

The kinase activity of IL-1 receptor-associated kinase 4 is required for interleukin-1 receptor/toll-like receptor-induced TAK1-dependent NFkappaB activation.

TLR7 IRAK4

3.19e-052197218794297
Pubmed

Two distinct GUCY2C circuits with PMV (hypothalamic) and SN/VTA (midbrain) origin.

LEPR GUCY2C

3.19e-052197231485718
Pubmed

Cbl-phosphatidylinositol 3 kinase interaction differentially regulates macrophage colony-stimulating factor-mediated osteoclast survival and cytoskeletal reorganization.

PIK3CG CBL

3.19e-052197220392263
Pubmed

Dynamic compartmentalization of protein tyrosine phosphatase receptor Q at the proximal end of stereocilia: implication of myosin VI-based transport.

MYO6 PTPRQ

3.19e-052197218412156
Pubmed

USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis.

USP1 KPNA2

3.19e-052197230531833
Pubmed

Feedback regulation of murine pantothenate kinase 3 by coenzyme A and coenzyme A thioesters.

PANK1 PANK3

3.19e-052197216040613
Pubmed

A therapeutic approach to pantothenate kinase associated neurodegeneration.

PANK1 PANK2

3.19e-052197230352999
Pubmed

Cocrystal structure of the ICAP1 PTB domain in complex with a KRIT1 peptide.

ITGB1BP1 KRIT1

3.19e-052197223695561
Pubmed

Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development.

CHD3 CHD4

3.19e-052197235568926
Pubmed

Regulation of human cytidine triphosphate synthetase 2 by phosphorylation.

CTPS2 CTPS1

3.19e-052197220739275
Pubmed

Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen.

CHD3 CHD4

3.19e-05219727560064
Pubmed

CIP2A-promoted astrogliosis induces AD-like synaptic degeneration and cognitive deficits.

PSEN1 CIP2A

3.19e-052197230594047
Pubmed

Presenilin-1/γ-secretase controls glutamate release, tyrosine phosphorylation, and surface expression of N-methyl-D-aspartate receptor (NMDAR) subunit GluN2B.

PSEN1 GRIN2B

3.19e-052197224025330
Pubmed

Monocyte expression and soluble levels of the haemoglobin receptor (CD163/sCD163) and the mannose receptor (MR/sMR) in septic and critically ill non-septic ICU patients.

CD163 IGF2R

3.19e-052197224637679
Pubmed

PI3Kγ Activates Integrin α4 and Promotes Immune Suppressive Myeloid Cell Polarization during Tumor Progression.

ITGA4 PIK3CG

3.19e-052197228963139
Pubmed

Polyphyllin I attenuates cognitive impairments and reduces AD-like pathology through CIP2A-PP2A signaling pathway in 3XTg-AD mice.

PSEN1 CIP2A

3.19e-052197233070372
Pubmed

Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163.

CD163 ADAM17

3.19e-052197220807704
Pubmed

Poly(ADP-ribose) Polymerase 1 Represses Liver X Receptor-mediated ABCA1 Expression and Cholesterol Efflux in Macrophages.

ABCA1 PARP1

3.19e-052197227026705
Pubmed

PI3Kγ ablation does not promote diabetes in db/db mice, but improves insulin sensitivity and reduces pancreatic β-cell apoptosis.

PIK3CG LEPR

3.19e-052197228904022
Pubmed

Directional ABCA1-mediated cholesterol efflux and apoB-lipoprotein secretion in the retinal pigment epithelium.

ABCA1 APOB

3.19e-052197230076206
Pubmed

Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-γ-stimulated cells.

DDB1 STAT2

3.19e-052197221698215
Pubmed

KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis.

ITGB1BP1 KRIT1

3.19e-052197211854171
Pubmed

USP1 promotes cholangiocarcinoma progression by deubiquitinating PARP1 to prevent its proteasomal degradation.

PARP1 USP1

3.19e-052197237821462
Pubmed

Exome sequencing: an efficient diagnostic tool for complex neurodegenerative disorders.

SACS APOB

3.19e-052197223043354
Pubmed

Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1.

DDB1 STAT2

3.19e-052197216227264
Pubmed

Long single alpha-helical tail domains bridge the gap between structure and function of myosin VI.

MYH6 MYO6

3.19e-052197218511944
Pubmed

Prevalence of ANGPTL3 and APOB gene mutations in subjects with combined hypolipidemia.

ANGPTL3 APOB

3.19e-052197222247256
Pubmed

Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen.

CHD3 CHD4

3.19e-05219728843877
Pubmed

Angiopoietin-like protein 3 modulates barrier properties of human glomerular endothelial cells through a possible signaling pathway involving phosphatidylinositol-3 kinase/protein kinase B and integrin alphaVbeta3.

PIK3CG ANGPTL3

3.19e-052197218535744
Pubmed

Krit1 modulates beta 1-integrin-mediated endothelial cell proliferation.

ITGB1BP1 KRIT1

3.19e-052197218812969
Pubmed

C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.

BLOC1S1 RGP1 BICD1 PRKD3 ADAM17 DOCK6 WASHC4 FAM83B TMEM106B IGF2R PLEKHM3 OCLN

3.40e-055041971234432599
Pubmed

C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.

SERBP1 MYO6 PSMD3 DDB1 PARP1 CTPS2 GMDS USP1 HSP90AB1 KPNA2 DSP POLD1 POLR2B SMC4 LDHB ERLIN1 DYNC1LI1 HSP90AB2P CTPS1 CNOT1

3.41e-0512571972037317656
InteractionJUP interactions

SERBP1 PSEN1 MYO6 CHD3 CHD4 PARP1 PTPRQ USP1 HSP90AB1 PSAT1 DSG3 DSP GMCL1 PDE4DIP CSTA DNAJC5 CTNNA2 OCLN

9.78e-0748519218int:JUP
InteractionPRKACA interactions

CDK16 ABCA1 PSEN1 ITGA4 ADCY5 NUAK1 AGAP2 HSP90AB1 EVL DSP SI GRIN2B CBL FAM83B IGF2R PDE4DIP DNAJC5 OCLN

2.55e-0651919218int:PRKACA
InteractionMCM2 interactions

TDRD15 MYH6 SERBP1 ORC6 SRP68 PSMD3 CHD3 CHD4 ITGA4 MAP3K1 PARP1 AP2A1 NUAK1 HSP90AB1 KPNA2 DSP SMC4 LDHB GDA HMCN1 CSTA MACF1 HSP90AB2P CTNNA2 CTPS1 CNOT1

1.29e-05108119226int:MCM2
InteractionEED interactions

CENPC MYO6 AS3MT SRP68 PSMD3 CHD3 CHD4 ITGA4 DDB1 PARP1 AP2A1 ADAM17 HSP90AB1 KPNA2 PSAT1 WASHC4 KDM5A DSP POLD1 CIP2A POLR2B SMC4 BRMS1L CBL GLMN IGF2R RMDN1 MACF1 CGNL1 CTPS1 CNOT1

1.72e-05144519231int:EED
InteractionLAMTOR1 interactions

CDK16 PSEN1 MYO6 SLC38A9 BLOC1S1 LMBRD2 PRKD3 PTPRD AP2A1 EPB41L5 RAB11FIP1 FAM83B TMEM106B ATP2C1 IGF2R DNAJC5 PLEKHM3 OCLN PLCH1 EDRF1

1.97e-0572219220int:LAMTOR1
InteractionKCNA3 interactions

SERBP1 MYO6 SRP68 PSMD3 DDB1 PARP1 HSP90AB1 KPNA2 DSP ICE2 CIP2A SMC4 EPB41L5 ARHGAP39 ERLIN1 FAM83B IGF2R MACF1 OCLN PLCH1 CTPS1 CNOT1

3.06e-0587119222int:KCNA3
GeneFamilyProtein tyrosine phosphatases, receptor type

PTPRD PTPRQ PTPRT

4.30e-04211293813
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

DOCK11 PRKD3 BMX AGAP2 TEC AFAP1 PLEKHM3

6.97e-042061297682
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS22 PTPRD PTPRQ NAV3 FAT4 FAT3 APOB GRIN2B HMCN1 CCBE1 CNTNAP4 MYOM2 PLCH1

2.05e-12184196132cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS22 PTPRD PTPRQ NAV3 FAT4 FAT3 APOB GRIN2B HMCN1 CCBE1 CNTNAP4 MYOM2 PLCH1

2.05e-12184196132b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RGS22 PTPRD PTPRQ NAV3 FAT4 FAT3 APOB GRIN2B HMCN1 CCBE1 CNTNAP4 MYOM2 PLCH1

2.05e-1218419613ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9

ABCA1 DOCK11 RGS22 TLR7 ITGA4 PIK3CG NAV3 FAT4 ABI3BP LEPR HMCN1 ABCA6

3.77e-111841961267164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMX GMDS DOCK6 SMC4 RAB11FIP1 IGF2R HMCN1 CORIN CGNL1 OCLN CTPS1 TEC

7.88e-1119619612dbf154b3d166ffd07be717dac8d8a3350ac63e16
ToppCelldroplet-Heart-nan-3m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMX NUAK1 DOCK6 SUPT20H SMC4 RAB11FIP1 IGF2R HMCN1 TXNRD3 CGNL1 OCLN

8.44e-1018919611fb2253b8463d08b3d28e952a31a23dea2c2d986b
ToppCelldroplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMX GMDS DOCK6 SMC4 RAB11FIP1 IGF2R HMCN1 CORIN CGNL1 OCLN CTPS1

1.24e-09196196117d5eaed189aa6116f3799be010139fb675ec65e0
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PTPRD PXDNL EVL SELENOP ABI3BP POLD1 AFAP1 ABCA6 CCBE1 DYNC1LI1 MACF1

1.45e-0919919611e1849505b92820a219c5a2c35492bdd55579fb48
ToppCellControl-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations)

NAV3 FAT4 ABI3BP FAT3 LEPR HMCN1 ABCA6 SUGCT CCBE1 PODN

1.13e-0818719610bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCelldroplet-Heart-nan-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMX NUAK1 DOCK6 SUPT20H SMC4 RAB11FIP1 HMCN1 TXNRD3 CGNL1 OCLN

1.25e-08189196108e583ec4df0f5b79ce5211cc99ecd8616d180bde
ToppCell5'-Adult-LargeIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ARHGEF38 BMX PIK3CG ELAPOR1 GRIN2B PTPRT OGDHL CTNNA2 CGNL1 TMEM63A

1.38e-081911961054f07e4de61735051498846afb44b1798bed8144
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TRPC6 NUAK1 NAV3 FAT4 ABI3BP FAT3 HMCN1 ABCA6 CCBE1 MACF1

1.38e-08191196106688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ABCA1 PTPRD EVL SELENOP ABI3BP GRM8 AFAP1 ABCA6 CCBE1 MACF1

1.86e-0819719610fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TRPC6 NAV3 FAT4 ABI3BP LEPR HMCN1 ABCA6 SUGCT CCBE1 PODN

1.86e-081971961044673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PTPRD NAV3 SELENOP FAT4 ABI3BP HMCN1 ABCA6 CCBE1 PODN MACF1

1.86e-081971961094a9603cbd3516fbcce871909693b88f20d41713
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

RGS22 TRPC6 NAV3 FAT4 ABI3BP HMCN1 ABCA6 SUGCT CCBE1 PODN

1.86e-08197196100dd71e399f253787fa546a7e90c5373180b89ffd
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PTPRD PXDNL EVL SELENOP ABI3BP AFAP1 ABCA6 CCBE1 DYNC1LI1 MACF1

1.95e-08198196100a4b19c3d5e65ecd24fc2ce80ac5276c813282c7
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ABCA1 PTPRD NUAK1 PXDNL EVL ABI3BP AFAP1 ABCA6 CCBE1 MACF1

2.04e-0819919610a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCellLPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type

ABCA1 PXDNL EVL SELENOP ABI3BP POLD1 AFAP1 ABCA6 CCBE1 DYNC1LI1

2.04e-0819919610211c3a08f2d484ab7a3368006767289088f0d957
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PTPRD NUAK1 PXDNL EVL SELENOP ABI3BP AFAP1 ABCA6 CCBE1 MACF1

2.04e-081991961030d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type

ABCA1 PXDNL EVL SELENOP ABI3BP POLD1 AFAP1 ABCA6 CCBE1 DYNC1LI1

2.04e-08199196101a0add79f4e34078b3475eb11c85a4234bda197c
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

ABCA1 PTPRD PXDNL EVL SELENOP ABI3BP ABCA6 CCBE1 DYNC1LI1 MACF1

2.14e-0820019610a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TRPC6 FAT4 ABI3BP LEPR HMCN1 ABCA6 SUGCT CCBE1 PODN CORIN

2.14e-082001961058b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PTPRD PXDNL EVL SELENOP ABI3BP AFAP1 ABCA6 CCBE1 DYNC1LI1 MACF1

2.14e-08200196103bdba9612cd7c612b76aa9abecc4a6529aabfc1c
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PTPRD PXDNL EVL SELENOP ABI3BP AFAP1 ABCA6 CCBE1 DYNC1LI1 MACF1

2.14e-082001961044a68bacdb3d5bf563bd35952176995850933a81
ToppCellBronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TRPC6 NUAK1 NAV3 FAT4 ABI3BP FAT3 HMCN1 ABCA6 CCBE1 PODN

2.14e-0820019610cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

PTPRD PXDNL EVL SELENOP ABI3BP AFAP1 ABCA6 CCBE1 DYNC1LI1 MACF1

2.14e-0820019610dc61016c61729f69649cfb21f6264e685ce83dea
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

ABCA1 PTPRD PXDNL EVL SELENOP ABI3BP AFAP1 ABCA6 CCBE1 MACF1

2.14e-0820019610bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell5'-Adult-Appendix-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ARHGEF38 BMX ELAPOR1 POLD1 GRIN2B OGDHL CTNNA2 CGNL1 TMEM63A

4.47e-081621969ded08da888d8c481f0f96d1e0bfd03d617966910
ToppCell5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ARHGEF38 BMX PIK3CG ELAPOR1 FAT3 GRIN2B PTPRT OGDHL CGNL1

6.12e-0816819698072d0496b7b730c4601009eaa69ec5366d26d73
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPRD NUAK1 PXDNL NAV3 ABI3BP FAT3 AFAP1 ABCA6 CCBE1

1.10e-07180196908ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPRD NUAK1 PXDNL NAV3 ABI3BP FAT3 AFAP1 ABCA6 CCBE1

1.10e-0718019699b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCellControl-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations)

TRPC6 NUAK1 NAV3 ABI3BP FAT3 HMCN1 ABCA6 CCBE1 MACF1

1.53e-07187196992d468dde81125d51daf7abd4703741abe1ab91c
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TRPC6 NUAK1 NAV3 ABI3BP FAT3 HMCN1 ABCA6 CCBE1 MACF1

1.91e-07192196999ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPRD NUAK1 PXDNL EVL ABI3BP FAT3 AFAP1 ABCA6 CCBE1

2.00e-071931969fb28717fadd06c3840636d25409ce80c9254bd34
ToppCellCOVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type

TRPC6 NAV3 SELENOP ABI3BP FAT3 HMCN1 ABCA6 CCBE1 PODN

2.48e-0719819693ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCellEpithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id

TRPC6 CHST9 ITGA4 NUAK1 DSG3 DSP FAM83B SUGCT CSTA

2.48e-0719819694235005c49fc2b29ad3a0ee6b608f0109d04f775
ToppCellnucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

TRPC6 NAV3 ABI3BP FAT3 HMCN1 ABCA6 CCBE1 PODN MACF1

2.48e-0719819698f52243ca8b9ba68a75ae411506a3a6de258eb97
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PTPRD PXDNL EVL SELENOP ABI3BP AFAP1 ABCA6 CCBE1 MACF1

2.70e-0720019699b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCellControl_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type

PTPRD PXDNL EVL SELENOP ABI3BP AFAP1 ABCA6 CCBE1 MACF1

2.70e-07200196964ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PTPRD PXDNL EVL SELENOP ABI3BP AFAP1 ABCA6 CCBE1 MACF1

2.70e-072001969b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

PTPRD PXDNL EVL SELENOP ABI3BP AFAP1 ABCA6 CCBE1 MACF1

2.70e-07200196950ca6550998e461ef26dd670351060bd940765a8
ToppCellParenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

PTPRD NAV3 FAT4 ABI3BP FAT3 HMCN1 ABCA6 CCBE1 MACF1

2.70e-072001969aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

PTPRD NAV3 FAT4 ABI3BP FAT3 HMCN1 ABCA6 CCBE1 MACF1

2.70e-072001969a510deaada669e690329183e18df02870bd204b3
ToppCellParenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TRPC6 NUAK1 NAV3 ABI3BP FAT3 HMCN1 ABCA6 CCBE1 PODN

2.70e-072001969cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type

PTPRD PXDNL EVL SELENOP ABI3BP AFAP1 ABCA6 CCBE1 MACF1

2.70e-072001969a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCellLung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

PTPRD NAV3 FAT4 ABI3BP FAT3 HMCN1 ABCA6 CCBE1 MACF1

2.70e-072001969dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell5'-Adult-Appendix-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ARHGEF38 BMX PIK3CG ELAPOR1 GRIN2B OGDHL CTNNA2 TMEM63A

4.70e-07156196858b9520fce6e259b36c3d59e82b712f5e7729e3e
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WDR64 PTPRQ FAT3 GRIN2B PTPRT HMCN1 CNTNAP4 CTNNA2

5.70e-071601968c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCellfacs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

WDR64 PTPRQ FAT3 GRIN2B PTPRT HMCN1 CNTNAP4 CTNNA2

5.70e-07160196825c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCellwk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

PTPRD B4GALNT3 SELENOP PCDHGB1 FAT3 ATP2C1 ABCA6 CCBE1

7.53e-07166196865dafed953b01a9830b54309af75c7a561e88336
ToppCelldroplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PTHLH BICD1 WDR93 BMX NUAK1 OLFM2 CGNL1 OCLN

1.33e-061791968a09647750eba9d93c5efc1db3b555fefb5eec7b5
ToppCellControl-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ITIH2 NUAK1 PXDNL ABI3BP FAT3 ABCA6 CCBE1

1.38e-061251967b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

TRPC6 PTPRD NUAK1 ABI3BP FAT3 HMCN1 ABCA6 CCBE1

1.44e-0618119689ede19228ba5c0668a9c06c915510b95585216ef
ToppCelldroplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMX GMDS DOCK6 SMC4 HMCN1 TXNRD3 CNTNAP4 CGNL1

1.57e-061831968b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5
ToppCelldroplet-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYO6 PTPRD ANGPTL3 SELENOP APOB SLC7A7 LDHB CGNL1

1.63e-061841968e02859bbac36dbbd55d7ae8cb5e46b764d7c6381
ToppCellCOVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations)

MYO6 SLC26A4 ARHGEF38 PTPRD ELAPOR1 B4GALNT3 DSP PLCH1

1.70e-061851968cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCellCOVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations)

MYO6 ARHGEF38 B4GALNT3 EPB41L5 RAB11FIP1 CGNL1 OCLN PLCH1

1.92e-061881968c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCellLPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPRD PXDNL EVL ABI3BP FAT3 ABCA6 CCBE1 DYNC1LI1

1.99e-0618919682a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPRD PXDNL EVL ABI3BP FAT3 AFAP1 ABCA6 CCBE1

2.07e-061901968841cd55861b43578d704418b9bc0af2e8b88323a
ToppCellPND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SERBP1 SLC26A4 CHD4 ITGA4 GLG1 HMCN1 MACF1 CGNL1

2.07e-061901968d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPRD PXDNL EVL ABI3BP FAT3 AFAP1 ABCA6 CCBE1

2.16e-061911968b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCellLV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper

KLHL24 MYH6 ADCY5 PXDNL B4GALNT3 PDE4DIP CORIN MYOM2

2.16e-06191196825f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCelldroplet-Heart-nan-18m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMX GMDS DOCK6 RAB11FIP1 IGF2R HMCN1 CGNL1 OCLN

2.24e-0619219680b9b2eaed45456d7d74ce78a64ef4a26ac2458fb
ToppCellfacs-Heart-LA-3m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMX NUAK1 GMDS DOCK6 IGF2R HMCN1 CGNL1 OCLN

2.24e-06192196814a816ef116aa992f86edab411f043cf7d07fe04
ToppCellfacs-Heart-LA-3m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

BMX NUAK1 GMDS DOCK6 IGF2R HMCN1 CGNL1 OCLN

2.24e-061921968847822514d747a21d5eb40e04ba9a023fd32bd65
ToppCellLPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPRD PXDNL EVL ABI3BP FAT3 AFAP1 ABCA6 CCBE1

2.24e-0619219686f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPRD PXDNL EVL ABI3BP FAT3 AFAP1 ABCA6 CCBE1

2.24e-061921968dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCellLPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPRD PXDNL EVL ABI3BP FAT3 AFAP1 ABCA6 CCBE1

2.24e-061921968deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

NUAK1 NAV3 ABI3BP FAT3 HMCN1 ABCA6 CCBE1 MACF1

2.33e-06193196899525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCellMesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor

PTPRD NUAK1 FAT4 ABI3BP FAT3 HMCN1 ABCA6 CCBE1

2.33e-061931968acad568621ed677031797b8c2e34dafea798d681
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ARHGEF38 CHST9 MAP3K1 ADGRF1 ABI3BP GRM8 OCLN PLCH1

2.42e-061941968e577d9e88390b36b5a09b97fe1026089892275a3
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPRD PXDNL EVL ABI3BP FAT3 AFAP1 ABCA6 CCBE1

2.42e-06194196889b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

TRPC6 MAP3K1 PTPRD FAT4 FAT3 ABCA6 CCBE1 MACF1

2.42e-061941968b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCellLPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

PTPRD PXDNL EVL ABI3BP FAT3 AFAP1 ABCA6 CCBE1

2.42e-06194196860622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCellCOVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations)

TRPC6 NUAK1 NAV3 ABI3BP FAT3 HMCN1 ABCA6 CCBE1

2.52e-061951968603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor

TRPC6 NUAK1 NAV3 ABI3BP FAT3 HMCN1 ABCA6 CCBE1

2.52e-061951968aa0add081881d349099d12efca5cdee098038d4e
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TRPC6 SELENOP ABI3BP FAT3 HMCN1 ABCA6 CCBE1 MACF1

2.52e-061951968df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor

TRPC6 NUAK1 NAV3 ABI3BP FAT3 HMCN1 ABCA6 CCBE1

2.52e-06195196861c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TRPC6 SELENOP ABI3BP FAT3 HMCN1 ABCA6 CCBE1 MACF1

2.52e-0619519684243190ad291d56694e2155954dbaa879c9d3844
ToppCellPCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

PTPRD SELENOP FAT4 ABI3BP FAT3 ABCA6 CCBE1 MACF1

2.61e-0619619681450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCellChildren_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor

NUAK1 NAV3 ABI3BP FAT3 HMCN1 ABCA6 CCBE1 PODN

2.61e-061961968bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCellBasal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id

TRPC6 CHST9 NUAK1 ELAPOR1 DSG3 DSP FAM83B SUGCT

2.61e-0619619683b66f3a79b3f2ebacb4ad646f179e505ab38d6f0
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PTPRD SELENOP ABI3BP FAT3 HMCN1 ABCA6 CCBE1 MACF1

2.61e-0619619689737a5f006d37b549f281e1863aca558e1e4dc99
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SELENOP ABI3BP FAT3 HMCN1 ABCA6 CCBE1 PODN MACF1

2.61e-06196196842e9828222a9663525d571633e8a454c30bfa7f8
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PTPRD SELENOP ABI3BP FAT3 HMCN1 ABCA6 CCBE1 MACF1

2.61e-061961968cecf82cd5e0a3835d655f5e7478578674a63ce25
ToppCellnucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

NAV3 ABI3BP FAT3 HMCN1 ABCA6 CCBE1 PODN MACF1

2.61e-0619619687d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

PTPRD SELENOP ABI3BP FAT3 HMCN1 ABCA6 CCBE1 MACF1

2.71e-06197196813896ec65ccda0b928c91d41112dc01b480036b7
ToppCellCOVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations)

PTPRD NAV3 ABI3BP AFAP1 HMCN1 ABCA6 SUGCT CCBE1

2.71e-061971968f1c8936986123a3151140c374fcd62d6705c530b
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

PTPRD SELENOP FAT4 ABI3BP FAT3 ABCA6 CCBE1 MACF1

2.71e-06197196811a4c417f035e554431a8f03be13b5eefa3530c0
ToppCellAdult-Mesenchymal|Adult / Lineage, Cell type, age group and donor

TRPC6 NUAK1 NAV3 ABI3BP HMCN1 ABCA6 CCBE1 PODN

2.82e-06198196826e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCellCOVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type

PTPRD NUAK1 NAV3 ABI3BP HMCN1 ABCA6 CCBE1 PODN

2.82e-061981968df3de77216f5c5d6141ec44d01c56b942f611838
ToppCellPCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

PTPRD SELENOP FAT4 ABI3BP FAT3 ABCA6 CCBE1 MACF1

2.82e-06198196817dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

PTPRD PXDNL EVL SELENOP ABI3BP AFAP1 ABCA6 MACF1

2.92e-061991968c2c42ecf20d1924edc2f899c01dfa5fcf3c210b9
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

ABCA1 PTPRD EVL ABI3BP POLD1 AFAP1 ABCA6 CCBE1

2.92e-0619919688b86c69aaf60feff53aa782559cfece7342a23de
ToppCellMesenchymal|World / Lineage, Cell type, age group and donor

TRPC6 NAV3 FAT4 ABI3BP FAT3 HMCN1 ABCA6 CCBE1

2.92e-0619919684bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCellBronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TRPC6 NAV3 ABI3BP FAT3 HMCN1 ABCA6 CCBE1 PODN

3.03e-062001968389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCellTracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

NAV3 FAT4 ABI3BP LEPR HMCN1 ABCA6 CCBE1 PODN

3.03e-062001968b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

TRPC6 NUAK1 NAV3 ABI3BP FAT3 HMCN1 ABCA6 CCBE1

3.03e-06200196834f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCellBiopsy_IPF-Mesenchymal-Myofibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type

PTPRD FAT4 ABI3BP HMCN1 ABCA6 CCBE1 PODN CORIN

3.03e-062001968c2c6f687c49ba790174b27c7b8b084af30b34c86
DrugTheobromine [83-67-0]; Down 200; 22.2uM; MCF7; HT_HG-U133A

CDK16 KLHL24 BICD1 PRKD3 GLG1 DOCK6 UTY CBL PDE4DIP CSTA TMEM63A

1.02e-06197193113334_DN
DrugD-pantothenoyl-L-cysteine

PANK1 PANK2 PANK3

2.38e-0641933CID000440217
DrugDasatinib

ABCA1 ORC6 NUAK1 CHAC1 KPNA2 NEMP1 SELENOP PSAT1 CIP2A SMC4 TEC TEX30 HMCN1 PRIM2 PODN OCLN

3.45e-0647819316ctd:D000069439
DrugLabetalol hydrochloride [32780-64-6]; Up 200; 11uM; PC3; HT_HG-U133A

ABCA1 PTHLH ITIH2 STAT2 FAT4 KDM5A GRM8 SUGCT PDE4DIP PLCH1

7.09e-06196193104473_UP
Diseasepantothenate kinase-associated neurodegeneration (implicated_via_orthology)

PANK1 PANK2 PANK3

1.11e-0641943DOID:3981 (implicated_via_orthology)
Diseasegalanin peptides measurement

GMDS SELENOP ABCA6

9.61e-0671943EFO_0010615
Diseaselipoprotein measurement, phospholipid measurement

TDRD15 ABCA1 DOCK6 APOB LEPR ABCA6

2.12e-05851946EFO_0004639, EFO_0004732
Diseaseesterified cholesterol measurement

TDRD15 ABCA1 DOCK6 APOB LEPR IGF2R ABCA6

2.30e-051281947EFO_0008589
Diseasetotal lipids in LDL measurement

TDRD15 ABCA1 APOB IGF2R ABCA6

2.36e-05521945EFO_0022308
Diseaselipid measurement, lipoprotein measurement

TDRD15 ABCA1 DOCK6 APOB LEPR ABCA6

2.94e-05901946EFO_0004529, EFO_0004732
Diseasetotal lipids in large LDL

TDRD15 ABCA1 APOB IGF2R ABCA6

3.70e-05571945EFO_0022163
Diseasecholesterol in large LDL measurement

TDRD15 ABCA1 APOB IGF2R ABCA6

3.70e-05571945EFO_0021901
DiseaseHENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 1

FAT4 CCBE1

4.30e-0521942C4012050
Diseaselipoprotein measurement

TDRD15 ABCA1 DOCK6 USP1 APOB LEPR

7.01e-051051946EFO_0004732
Diseaselipoprotein A measurement

TDRD15 PSMD3 IP6K2 APOB IGF2R ABCA6

1.00e-041121946EFO_0006925
Diseasefree cholesterol measurement

TDRD15 ABCA1 APOB LEPR IGF2R ABCA6

1.05e-041131946EFO_0008591
Diseasetotal cholesterol measurement, low density lipoprotein cholesterol measurement

TDRD15 ABCA1 APOB LEPR IGF2R ABCA6

1.11e-041141946EFO_0004574, EFO_0004611
DiseaseHypogonadotropic hypogonadism

NR0B1 POLD1 LEPR

1.20e-04151943C0271623
Diseaseresponse to statin, LDL cholesterol change measurement

TDRD15 ZNF98 APOB

1.20e-04151943EFO_0007804, GO_0036273
DiseasePrimary hypogonadism

NR0B1 POLD1 LEPR

1.20e-04151943C0948896
DiseaseHypogonadism, Isolated Hypogonadotropic

NR0B1 POLD1 LEPR

1.20e-04151943C3489396
Diseaseangiopoietin-related protein 3 measurement

ANGPTL3 USP1

1.28e-0431942EFO_0020148
DiseaseHennekam syndrome (is_implicated_in)

FAT4 CCBE1

1.28e-0431942DOID:0060366 (is_implicated_in)
DiseaseHennekam lymphangiectasia-lymphedema syndrome

FAT4 CCBE1

1.28e-0431942C0340834
Diseasephospholipids:total lipids ratio

TDRD15 ABCA1 DOCK6 USP1 APOB IGF2R ABCA6 MACF1

1.37e-042271948EFO_0020946
Diseasevery low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio

TDRD15 ABCA1 DOCK6 USP1 APOB LEPR IGF2R ABCA6 MACF1

1.41e-042911949EFO_0008317, EFO_0020946
DiseaseHypogonadism

NR0B1 POLD1 LEPR

1.47e-04161943C0020619
Diseasesleep duration, high density lipoprotein cholesterol measurement

ABCA1 DOCK6 APOB AFAP1 MACF1 CGNL1

1.54e-041211946EFO_0004612, EFO_0005271
Diseaseapolipoprotein A 1 measurement

ABCA1 ADCY5 CD163 XPO6 ANGPTL3 DOCK6 USP1 NEMP1 OR8J2 APOB LEPR ERLIN1 TMEM106B ABCA6 MACF1 CNOT1

1.65e-0484819416EFO_0004614
DiseaseAstrocytosis

ITGA4 GRM8 LEPR

1.78e-04171943C3887640
DiseaseGliosis

ITGA4 GRM8 LEPR

1.78e-04171943C0017639
Diseasetriglycerides in large LDL measurement

TDRD15 ABCA1 APOB IGF2R

1.83e-04431944EFO_0022319
Diseasecholesteryl ester measurement, low density lipoprotein cholesterol measurement

TDRD15 ABCA1 APOB LEPR IGF2R ABCA6

1.91e-041261946EFO_0004611, EFO_0010351
Diseasedocosahexaenoic acid measurement

TDRD15 ABCA1 DOCK6 USP1 APOB CTNNA2

2.00e-041271946EFO_0007761
Diseasecholine measurement

TDRD15 ABCA1 DOCK6 APOB LEPR PLCH1

2.27e-041301946EFO_0010116
DiseaseColorectal Carcinoma

ABCA1 PARP1 PTPRD SACS EVL SELENOP ZNF560 POLD1 APOB PTPRT ABCA6 GUCY2C OLFM2 EDRF1

2.44e-0470219414C0009402
Diseasecystathionine measurement

TEC CTNNA2 TEC

2.51e-04191943EFO_0010474
Diseasetyrosine-protein kinase TEC measurement

TEC TEC

2.56e-0441942EFO_0020830
Diseasetotal lipids in lipoprotein particles measurement

TDRD15 ABCA1 DOCK6 APOB

2.81e-04481944EFO_0022309
Diseasephospholipids in medium LDL measurement

TDRD15 APOB IGF2R ABCA6

3.05e-04491944EFO_0022183
Diseasefree cholesterol in large LDL measurement

TDRD15 ABCA1 APOB ABCA6

3.56e-04511944EFO_0022176
DiseaseAttention Deficit Disorder

AS3MT PTPRD GRM8

3.93e-04221943C0041671
DiseaseMinimal Brain Dysfunction

AS3MT PTPRD GRM8

3.93e-04221943C1321905
Diseasecholesteryl ester measurement, intermediate density lipoprotein measurement

TDRD15 ABCA1 APOB IGF2R ABCA6

3.99e-04941945EFO_0008595, EFO_0010351
Diseasephospholipids in medium HDL measurement

ABCA1 DOCK6 USP1 APOB

4.75e-04551944EFO_0022295
Diseasetriglycerides in LDL measurement

TDRD15 ABCA1 APOB IGF2R

5.09e-04561944EFO_0022320
DiseaseAttention deficit hyperactivity disorder

AS3MT PTPRD GRM8

5.12e-04241943C1263846
DiseaseColorectal Neoplasms

ABCA1 PARP1 PTPRD EVL SELENOP POLD1 ABCA6 GUCY2C

5.22e-042771948C0009404
Diseasetotal lipids in medium HDL measurement

ABCA1 DOCK6 USP1 APOB

5.82e-04581944EFO_0022310
Diseasefree cholesterol in medium HDL measurement

ABCA1 DOCK6 USP1 APOB

5.82e-04581944EFO_0022267
Diseasephosphatidylcholine measurement

TDRD15 ABCA1 PSMD3 DOCK6 USP1 APOB SUGCT MACF1

6.14e-042841948EFO_0010226
Diseasephospholipids in small LDL measurement

TDRD15 APOB IGF2R ABCA6

6.22e-04591944EFO_0022297
DiseasePure gonadal dysgenesis 46,XY

MAP3K1 NR0B1

6.34e-0461942cv:C2936694
Diseaseinterleukin-1 receptor-like 1 measurement

IL18RAP IL1RL1

6.34e-0461942EFO_0801713
DiseaseLissencephaly

MACF1 CTNNA2

6.34e-0461942C0266463
Diseaseneuroimaging measurement, brain volume measurement

USP34 RGP1 MAP3K1 BICD1 NUAK1 NAV3 FAT3 AFAP1

6.43e-042861948EFO_0004346, EFO_0006930
Diseasefatty acid measurement

TDRD15 ABCA1 PTPRD DOCK6 USP1 KLB APOB IGF2R MACF1 CTNNA2

6.61e-0443619410EFO_0005110
Diseasephospholipids in HDL measurement

ABCA1 DOCK6 USP1 APOB

7.05e-04611944EFO_0022293
Diseasetriglycerides in medium LDL measurement

TDRD15 ABCA1 APOB IGF2R

7.50e-04621944EFO_0022322
Diseasetriglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement

TDRD15 ABCA1 USP1 APOB IGF2R ABCA6 MACF1

7.53e-042251947EFO_0008317, EFO_0020947
Diseasetotal lipids in HDL measurement

ABCA1 DOCK6 USP1 APOB

7.97e-04631944EFO_0022307
DiseaseSemantic Dementia

PSEN1 TMEM106B

8.84e-0471942C0338462
Diseasehepatocyte growth factor receptor measurement

PSG6 ABCA6

8.84e-0471942EFO_0008153
DiseaseChild Development Disorders, Specific

AS3MT CHD4 CBL

9.01e-04291943C0085997
DiseaseChild Development Deviations

AS3MT CHD4 CBL

9.01e-04291943C0085996
Diseaselow density lipoprotein cholesterol measurement, lipid measurement

TDRD15 ABCA1 APOB LEPR ABCA6

9.60e-041141945EFO_0004529, EFO_0004611
Diseaseceramide measurement

ABCA1 PSMD3 APOB TEC SLCO5A1 CORIN TEC

9.71e-042351947EFO_0010222
DiseaseDevelopmental Disabilities

AS3MT CHD4 CBL

9.97e-04301943C0008073
Diseasecommon carotid intimal medial thickness

TDRD15 APOB GRM8 DNAJC5

1.00e-03671944EFO_0004860
Diseasedehydroepiandrosterone sulphate measurement

SERBP1 TRPC6 PTPRD ZNF98

1.06e-03681944EFO_0007001
DiseaseC-reactive protein measurement

USP34 TDRD15 ABCA1 CCDC168 IL18RAP ADCY5 MAP3K1 HFM1 KIAA2012 IP6K2 APOB CBL LEPR GLMN ABCA6 DNAJC5 MACF1 IL1RL1

1.07e-03120619418EFO_0004458
Diseasevery low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio

TDRD15 ABCA1 USP1 APOB IGF2R ABCA6 MACF1

1.07e-032391947EFO_0008317, EFO_0020945
Diseasealkaline phosphatase measurement

USP34 TDRD15 SAMD9 SLC26A4 CHD3 ADCY5 XPO6 HFM1 B4GALNT3 APOB LEPR TMEM106B ABCA6 SLF2 MACF1 CNOT1

1.16e-03101519416EFO_0004533
Diseaseesterified cholesterol measurement, intermediate density lipoprotein measurement

TDRD15 APOB

1.17e-0381942EFO_0008589, EFO_0008595
Diseaseholoprosencephaly (is_implicated_in)

PLCH1 CNOT1

1.17e-0381942DOID:4621 (is_implicated_in)
DiseaseFanconi anemia (implicated_via_orthology)

USP1 FAN1

1.17e-0381942DOID:13636 (implicated_via_orthology)
Diseasepantothenate measurement

ABCA1 PANK2

1.17e-0381942EFO_0021034
DiseaseHantavirus hemorrhagic fever with renal syndrome (is_marker_for)

CD163 IL1RL1

1.17e-0381942DOID:11266 (is_marker_for)
Diseasecirculating alpha-Klotho measurement

CHST9 B4GALNT3

1.17e-0381942EFO_0020102
DiseasePrimary Progressive Nonfluent Aphasia

PSEN1 TMEM106B

1.17e-0381942C0751706
Diseasefree cholesterol measurement, high density lipoprotein cholesterol measurement

TDRD15 ABCA1 DOCK6 USP1 KLB APOB LEPR ABCA6

1.20e-033151948EFO_0004612, EFO_0008591
Diseasefeeling tense measurement

AS3MT TMEM106B CTNNA2

1.32e-03331943EFO_0009596
Diseasemyeloid white cell count

USP34 SLC38A9 TRPC6 NAIP PSMD3 ITGA4 ADCY5 XPO6 GLG1 HFM1 SELENOP LRRK1 LEPR GLMN TREML2

1.41e-0393719415EFO_0007988
Diseasepancreatitis (implicated_via_orthology)

CPA1 LEPR

1.50e-0391942DOID:4989 (implicated_via_orthology)
DiseasePancreatitis, Chronic

PTHLH CPA1

1.50e-0391942C0149521
Diseaselow tension glaucoma

ABCA1 GMDS

1.50e-0391942EFO_1001022
DiseaseBehavioral variant of frontotemporal dementia

PSEN1 TMEM106B

1.50e-0391942C4011788
Diseaserectum cancer (is_implicated_in)

CHD4 MAP3K1

1.50e-0391942DOID:1993 (is_implicated_in)
Diseasefree cholesterol in small HDL measurement

TDRD15 ABCA1 DOCK6

1.57e-03351943EFO_0022270
DiseaseCardiomyopathies

MYH6 PSEN1 ADCY5 PARP1 DSP

1.72e-031301945C0878544
DiseaseAlzheimer's disease (is_implicated_in)

ABCA1 PSEN1 PARP1 ADAM17 GRIN2B

1.84e-031321945DOID:10652 (is_implicated_in)
Diseasefree cholesterol to total lipids in large VLDL percentage

TDRD15 APOB ABCA6

1.84e-03371943EFO_0022281
Diseaseprotein intake measurement

KLB CTNNA2

1.87e-03101942EFO_0010810
Diseasevery low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio

TDRD15 ABCA1 USP1 APOB IGF2R ABCA6 MACF1

1.89e-032641947EFO_0008317, EFO_0020944
Diseaseomega-6 polyunsaturated fatty acid measurement

TDRD15 ABCA1 DOCK6 APOB IGF2R ABCA6

1.99e-031971946EFO_0005680
DiseaseDegenerative Diseases, Central Nervous System

PSEN1 PANK2 SELENOP

2.15e-03391943C0270715
DiseaseNeurodegenerative Disorders

PSEN1 PANK2 SELENOP

2.15e-03391943C0524851
DiseaseDegenerative Diseases, Spinal Cord

PSEN1 PANK2 SELENOP

2.15e-03391943C0751733
DiseaseHypercholesterolemia

ABCA1 ANGPTL3 APOB

2.15e-03391943C0020443
Diseasefree cholesterol measurement, low density lipoprotein cholesterol measurement

TDRD15 ABCA1 APOB IGF2R ABCA6

2.16e-031371945EFO_0004611, EFO_0008591
Diseaseinterleukin 1 receptor-like 1 measurement

IL18RAP IL1RL1

2.27e-03111942EFO_0008168
Disease46,XY partial gonadal dysgenesis

MAP3K1 NR0B1

2.27e-03111942C4510744
Diseaseserum ST2 measurement

IL18RAP IL1RL1

2.27e-03111942EFO_0005416
Diseasecholesterol in very small VLDL measurement

TDRD15 APOB ABCA6

2.31e-03401943EFO_0022231

Protein segments in the cluster

PeptideGeneStartEntry
TYYLSVNRNKKSIAV

SUGCT

101

Q9HAC7
DRSIQKVYKTYNGTN

TSPAN3

116

O60637
KSSEEITQYIQSYKG

NAIP

231

Q13075
KTLRTLQYDGFKTVY

C21orf140

31

B9A014
QESASKEAYYLGKIL

BICD1

96

Q96G01
IATALEYVYKGQLQS

BLOC1S1

136

P78537
SKLRSYQYVKLSGNF

B4GALNT3

841

Q6L9W6
SAIYSKYANGIEIQL

ADGRF1

171

Q5T601
TSLAQYDSNSKKIYG

BMX

211

P51813
AVVKRTGSNAAQYKY

AFAP1

541

Q8N556
TKFNYGSIIKAIYQA

CPA1

346

P15085
KLLSTYSAEELYQAK

ARHGEF38

576

Q9NXL2
EYLELKKYQAIASNS

ERLIN1

281

O75477
SNYTTVKIKNGKVYF

FAT4

4266

Q6V0I7
SDYLVKTYVQIIAKS

ABCA1

1506

O95477
SYNGAIIVSGKQKDY

ABCA6

946

Q8N139
NLLSSNKYTEKQIGY

AP2A1

81

O95782
NKYTEKQIGYLFISV

AP2A1

86

O95782
FYKEYLSVIIAKNGS

CNTNAP4

1061

Q9C0A0
KKKYVTLSSNGFLLY

AGAP2

696

Q99490
GLEKIYSIVKQSNYV

ANGPTL3

316

Q9Y5C1
ITKATLNYLNGDYEV

ADCY5

606

O95622
YTNTTNKEEKIQLAY

LVRN

846

Q6Q4G3
VIKYCTTYQSKGQTL

ATP2C1

486

P98194
KSTSKYIYQTLFLNG

GMCL1

91

Q96IK5
GSLFYNKYQSNVVVK

OLFM2

276

O95897
VNDTKGVAISTYAKY

ARHGAP39

836

Q9C0H5
ASYKKGTLEYLQLNT

GUCY2C

1051

P25092
YNRLKQVKGSADYKS

OCLN

481

Q16625
DIVKGTNSYYKLQLL

PARP1

561

P09874
QTLKYTIKYIGELTD

MSGN1

166

A6NI15
LTESPKYIQKQISYN

SERBP1

231

Q8NC51
AKITSDYQATQKITY

DSG3

71

P32926
ISSKKLVDYILGTYQ

DSG3

396

P32926
ANYLTKIYGLTFGQK

PODN

176

Q7Z5L7
KSIYYITGESKEQVA

HSP90AB1

481

P08238
DSTYQYIKGSADIKS

INPP1

156

P49441
LYRTYQSKDQTLGDK

IL18RAP

391

O95256
TGKNSCYENISELKY

MAP10

686

Q9P2G4
YQASTSELYGKVQEI

GMDS

151

O60547
IYGNQDTSSQLKKFY

ITIH2

476

P19823
SEVLYYTVEKKGNIS

IP6K2

156

Q9UHH9
SVYATSLQSDVNYKK

NRAP

1091

Q86VF7
TATEDQKIYIYTLKG

LRRK1

1596

Q38SD2
QKAILSKFLYYSING

EDRF1

201

Q3B7T1
QKSIYYITGESKEQV

HSP90AB2P

256

Q58FF8
SKGKQSYTYIIEENT

ELAPOR1

531

Q6UXG2
LQYGAALIYTSVKEN

DYNC1LI1

276

Q9Y6G9
NSVYGKVLDQYKSLI

FSIP2

5026

Q5CZC0
NYIYKTLGVNKQTEN

FAM83B

636

Q5T0W9
TGKVYYDLVKERSSQ

OGDHL

891

Q9ULD0
ESTSKNYYKLVIAGA

PCDHGB1

391

Q9Y5G3
SSSKNYYKLVTDGAL

PCDHGB2

396

Q9Y5G2
KEKLNDTYVNVGLYS

NEMP1

121

O14524
GKTYLANKLAEYVIT

NAV3

2061

Q8IVL0
INYSIVKGLKYNQAT

EVL

61

Q9UI08
LYASKESYNEKTQQT

KIAA2012

286

Q0VF49
TLFQNESGSKYYKEI

PRKD3

446

O94806
NNDKKSIYYLGVTSI

LEPR

1071

P48357
SLLLQIVYGNYESKK

KRIT1

556

O00522
ANKRKYTSSYEALKG

KCNU1

316

A8MYU2
SKQYQNILKSGTLYR

PLEKHM3

356

Q6ZWE6
KSLTYYTNLQVKTGQ

TMEM63A

281

O94886
ILTDATKRNIYDKYG

DNAJC5

66

Q9H3Z4
YQITNKSTEYKVIGH

GRM8

476

O00222
AKVEAIQSGSNYAYL

KDM5A

1006

P29375
YGLSTVYLNKLKTVD

MACF1

1146

Q9UPN3
TAGYAKRKVQLTVYV

HMCN1

1056

Q96RW7
ETDTIYYKNISGFKT

PTPRQ

1326

Q9UMZ3
ETNGVITLYEINYKA

PTPRT

511

O14522
KSIRKYLTSNVAYGS

PANK3

46

Q9H999
LTYASQKYKNHIGTE

HFM1

121

A2PYH4
NESVYKASLSLIEKY

KPNA2

481

P52292
LNISTKEYAYLKGTV

NR0B1

371

P51843
KSIRKYLTSNVAYGS

PANK2

246

Q9BZ23
ILAVYSKDNYKRVTG

PANK2

396

Q9BZ23
LVTKKTISYYGCAAQ

OR8J2

86

Q8NGG1
VSYVKGTEQYQSKLE

PRIM2

61

P49643
VTQESQKKRSAQYSY

PXDNL

1311

A1KZ92
SYGTKILYQNTEALQ

DECR1

26

Q16698
LIAQDYKVSYSLAKS

GLG1

361

Q92896
KNTASLKYENYELTL

APOB

1556

P04114
YELTLKSDTNGKYKN

APOB

1566

P04114
RYSGKTEYQTTKTNK

EPB41L5

346

Q9HCM4
RTGYANVTIYKKQSD

IL1RL1

96

Q01638
ASDGKVTRTAYNLYK

ICE2

876

Q659A1
LQYVYTGKVKITTEN

KLHL24

121

Q6TFL4
KYKYIVLNSQASQAG

BCL6B

196

Q8N143
NYKSGLVQKSLYIQA

BCLAF3

661

A2AJT9
GSYILNSYKDEKNSK

DOCK11

201

Q5JSL3
SKLDSQKAYIQITYV

DOCK6

1811

Q96HP0
ASTKYQKVYGTAAVN

CTNNA2

886

P26232
ALIGETVNNYRSTKY

CENPC

386

Q03188
KQILYNYLKEGSTDN

CGNL1

556

Q0VF96
YATVYKGKSKLTDNL

CDK16

176

Q00536
TVTKYSGSLLLQKKY

CACNA2D4

91

Q7Z3S7
GKTIQTIVFLYSLYK

CHD3

766

Q12873
AGIYNETTKQKLGIY

DSP

2261

P15924
KYITGDKVLASNTYL

CCBE1

231

Q6UXH8
AYQVQGEQVSKALKY

CHAC1

96

Q9BUX1
AGNSYIKYRLSENSK

FAT3

3841

Q8TDW7
KDVQTYYGQVLKRSA

AS3MT

11

Q9HBK9
LSYVGTLQKVYFKSN

CORIN

66

Q9Y5Q5
TNETYGKLEAVQYKT

CSTA

31

P01040
KQNQVKFGSYLGYSV

ITGA4

241

P13612
NYYKTTSSEINAIVG

EFHB

696

Q8N7U6
YTSVYDKNNLLTNKT

GDA

261

Q9Y2T3
VANAKGLQYYSTLLD

KLB

166

Q86Z14
VESAYEVIKLKGYTN

LDHB

236

P07195
SKLYISQLQKGKYSI

BRMS1L

306

Q5PSV4
SQGYSYQDIQKALVI

CBL

866

P22681
YKGYVNNTTVAVKKL

IRAK4

201

Q9NWZ3
ASNLLKRYAEKYSGV

FIGNL2

56

A6NMB9
DTGKLKYTLSYLNDI

CCDC168

4606

Q8NDH2
CGSALKTSYQVYSKI

CD163

416

Q86VB7
GKTVQTAVFLYSLYK

CHD4

756

Q14839
YTKTVLNYLQSSGKQ

SACS

586

Q9NZJ4
KLQSYTEGYGKNTSL

SLC38A9

106

Q8NBW4
TKQLVESKYTVENGY

POLD1

731

P28340
TLEYGNYTALAKVQI

PKD1L1

746

Q8TDX9
YLIGKDITNKLYSLN

BVES

251

Q8NE79
TTYTGSYRKKQLDKS

C4orf51

46

C9J302
TAKYNACILEYKQSG

DDB1

81

Q16531
KYGIKVSTSDQYDVL

ITGB1BP1

116

O14713
RNSTYEKLDLKVYGT

KIF2B

341

Q8N4N8
EKQNGIITEYSIKYT

PTPRD

636

P23468
KSIRKYLTSNTAYGK

PANK1

271

Q8TE04
ILAVYSKDNYKRVTG

PANK1

421

Q8TE04
SKYGAFKESVVINYT

MAP3K1

1336

Q13233
KFYQLSATGQKLYVR

FAN1

406

Q9Y2M0
YINKLDSQGKYTLFR

GLMN

391

Q92990
SSNVSYKYSKVNKEE

IGF2R

2346

P11717
AQKGAYIELTLQTYQ

MRPS22

336

P82650
IGVKSAYVSYDVQKR

TMEM106B

126

Q9NUM4
TKESYAIQYLQKSLE

UTY

261

O14607
AYAVIQVGKEKYATS

RAB11FIP1

41

Q6WKZ4
TLSVQCSYKGYKNRV

TREML2

36

Q5T2D2
ISFTVKYTYQGLKQE

STAT2

431

P52630
KYTYQGLKQELKTDT

STAT2

436

P52630
KSVSFYTRKDGQLIY

PSEN1

101

P49768
IYLNAKVKGYVSNIS

TDRD15

1291

B5MCY1
SNYVTGKKSNNLDQY

TEC

231

P42680
TGKIKTALIENAIYY

LMBRD2

141

Q68DH5
SFRGQSVKYVYKLTI

RGP1

126

Q92546
KFYVSLGEASYTQTK

RGS22

191

Q8NE09
KTNRTLYLFGVTKYI

PSG6

196

Q00889
NSYISDTLGQVYKSK

SAMD9

1116

Q5K651
SKTNRTLYLFGVTKY

PSG9

196

Q00887
SVLEYKVQAGNSSLY

PSAT1

226

Q9Y617
VKTYLNENGYAVSGK

SLCO5A1

626

Q9H2Y9
NNLTTGKIYQYVINK

CTPS1

86

P17812
VNVQKISNLLSDYGY

POLR2B

1006

P30876
GILKKTQQRESGYYS

NUAK1

466

O60285
AYLIKLSGLNKETYQ

ORC6

66

Q9Y5N6
ETKDTIQNGNYILYT

SI

836

P14410
LSLASKYLAKGTNIY

SLF2

136

Q8IX21
QSVQQVYYSIGALAK

MYH6

416

P13533
LKKEGYSNISYIVVN

SELENOP

76

P49908
KTKLEAQAYTAYLSG

SRP68

181

Q9UHB9
KNIYLNSGLTSTKNY

ADAM17

376

P78536
KLTYNVKIFYSGANI

CIP2A

126

Q8TCG1
FDLKGIYTRLNTYTK

CHST9

261

Q7L1S5
SQISYLVDNLTKKNY

CNOT1

11

A5YKK6
SSESKGKVQLLYYVN

PIK3CG

451

P48736
TDDYLSNLIKAKSYI

RNF17

216

Q9BXT8
SEGKYSKVYALRTQK

TSGA13

186

Q96PP4
NLYKDNNITTGKIYQ

CTPS2

81

Q9NRF8
SSDKITTGYKYKRLQ

SETDB2

321

Q96T68
YSLYDQAEKLVSKSV

PSMD3

261

O43242
NVSTKNYNGVLSIIY

SLC26A4

241

O43511
TLGIALKFYNYSITK

TMPRSS7

406

Q7RTY8
SGETEKLYQLLTQYK

RMDN1

96

Q96DB5
TIKKSGASYAYILEA

SLC7A7

96

Q9UM01
SGRKSVFQKLYDLYI

SUPT20H

31

Q8NEM7
RLIGIYKTYNITKSV

SMC4

1261

Q9NTJ3
YNSYKTQAGSSKTEK

TTC14

601

Q96N46
KAYKSVLNYLKTSGE

TEX30

76

Q5JUR7
GRYLTQETNKVETYK

PTHLH

101

P12272
CYKYGQTLDLSKNSI

TLR7

491

Q9NYK1
DVKTQSISYLAYQGA

PLCH1

1426

Q4KWH8
LGTTYKRDLNSYKVQ

SAXO2

46

Q658L1
AKGFSIYNLYSAKQI

WDR93

121

Q6P2C0
LTNNDLYRIFSKYGK

ZCRB1

21

Q8TBF4
VQLKNYGKFLEEYTS

WASHC4

26

Q2M389
LTTTQNKIFQYDKYV

ZNF98

146

A6NK75
ATNKKGQETYYTAAQ

TXNRD3

286

Q86VQ6
YNYSIIGTFTVKLKV

TMEM130

196

Q8N3G9
IKKLTGSTERYDQNY

ZNF765

116

Q7L2R6
SSQVKEYLQSLSYKD

TEX26

256

Q8N6G2
DLTKVTLGDNVKYYN

TRPC6

566

Q9Y210
INSYYINGKTGLEKE

USP34

1121

Q70CQ2
VKVTLYGSQIKLYNI

XPO6

591

Q96QU8
KIYLSDSLTGKFYNI

ABI3BP

981

Q7Z7G0
TLELQIAKDKNYGSY

ZP4

316

Q12836
NKISYVVQSLKEYEG

USP1

731

O94782
ENYKNLSSVGYQLFK

ZNF560

141

Q96MR9
QYAKDLLSLYNKTST

ZNF560

246

Q96MR9
YIITSKGKGNANLEY

VTCN1

131

Q7Z7D3
YKAQGSSQENYFVIK

WDR64

191

B1ANS9
IYSSEAIKSYQGKSL

MYO6

106

Q9UM54
YLKVSDLQQGKTYVF

MYOM2

871

P54296
SELQIYEALYGNSKK

PDE4DIP

2011

Q5VU43
TGTEKLIETYFSKNY

PLP1

41

P60201
SVKFTYDLYLVTNGK

GRIN2B

471

Q13224